Clinical Trials in Spain / NCT07083999
Active, not recruiting
Observational
Observational Study to Evaluate Fertility in Women Between 32 and 38 Years Old Treated With the Ovosicare® Fertility
NCT07083999 · tracked via the Priya Life Science Spain tracker
Condition(s) studied
Fertility
Study summary
The goal of this observational study is to evaluate whether supplementation with the Ovosicare® Fertility food supplement increases the possibility of becoming pregnant in women aged between 32 and 38 years who have been trying to become pregnant for at least 6 months before starting supplementation.
Eligibility
Inclusion Criteria:
1. \- Women who agree to participate in the study by signing the informed consent.
2. \- Between 32 and 38 years old.
3. \- Who come to doctor´s office stating that they have been trying to get pregnant for at least 6 months.
Exclusion Criteria:
1. \- BMI \> 30 kg/m2.
2. \- Existence of severe male factor subfertility according to the criteria of the World Health Organization (WHO), with at least one analysis obtained in the last 6 months with one or more variables with values of:
* Azoospermia
* Progressive motility \<25%
* Normal morphology ≤2%
3. \- Pregnant or breastfeeding women.
4. \- Patients with type 1 diabetes or thyroid disease.
5. \- Patients with any assisted reproduction technique scheduled during the duration of the study.
6. \- Patients who have used or taken systemic steroids, anticonvulsants, antiretroviral treatment for HIV or hepatitis B in the last month.
7. \- Patients with a known allergy to any of the components of Ovosicare® Fertility.
8. \- Any other situation that, in the medical opinion, advises against treatment with Ovosicare® Fertility or that may make patient follow-up difficult.
9. \- Patients with suspected endometriosis.
10. \- Existence of fibroids affecting the endometrial cavity.
11. \- Patients with 2 or more previous abortions.
12. \- Patients with a current diagnosis of a high-risk human papillomavirus (HPV) cervical lesion.
Primary outcome measure(s)
- Evaluate the rate of spontaneous pregnancy in women between 32 and 38 years old after a maximum of 6 months of supplementation with Ovosicare Fertility — From enrollment to visit 2 (9 months)
Women suspected of being pregnant will undergo a blood test to detect the hormone beta-hCG and a transvaginal ultrasound to confirm the pregnancy.
Trial sites (27)
| Facility | City | Region | Status |
|---|---|---|---|
| CM Sitges | Sitges | Barcelona | |
| HU de Getafe | Getafe | Madrid | |
| Clínica Rv Benalmádena | Benalmádena | Malaga | |
| H García Orcoyen | Estella-Lizarra | Navarre | |
| CP Dr. Andrade Andrade | A Coruña | Spain | |
| CP Dra. Domenech Casanova | Alicante | Spain | |
| H Vega Baja de Orihuela | Alicante | Spain | |
| Clinica Alboran | Almería | Spain | |
| CP Dr. Aragón Albillos | Almería | Spain | |
| CM Teknon | Barcelona | Spain | |
| CP Dra. Mallafre | Barcelona | Spain | |
| HU Vall d'Hebron | Barcelona | Spain | |
| OBS Ginecólogos Burgos | Burgos | Spain | |
| Clínica Attella | Castelló | Spain | |
| HU de Donostia | Donostia / San Sebastian | Spain | |
| CP Dra. Skouri-Bnihech Tioua | Granada | Spain | |
| CHU Insular - H Materno-Infantil | Las Palmas | Spain | |
| Clínica Palacios | Madrid | Spain | |
| Gymeiaka Dra. Oltra Badui | Madrid | Spain | |
| Gymeiaka Dra. Pavón Sanz | Madrid | Spain | |
| HU La Paz | Madrid | Spain | |
| Clínica Imar | Murcia | Spain | |
| Ancla Clínica Ginecológica | Pontevedra | Spain | |
| HG de la Santísima Trinidad | Salamanca | Spain | |
| CP Dra. Sánchez Quintana | Seville | Spain | |
| HU i Politècnic la Fe | Valencia | Spain | |
| Centro Ginecológico Bolonia | Zaragoza | Spain |
More Procare Health Iberia S.L. trials in Spain
Other trials for the same condition
Official registry record
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07083999 on ClinicalTrials.gov ↗ ← All trials in Spain